We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20B
AUM Growth
+$1.88B
Cap. Flow
+$1.7B
Cap. Flow %
8.49%
Top 10 Hldgs %
14%
Holding
1,901
New
565
Increased
401
Reduced
415
Closed
510

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$328M
2
C icon
Citigroup
C
+$183M
3
CBOE icon
Cboe Global Markets
CBOE
+$152M
4
MCD icon
McDonald's
MCD
+$130M
5
QSR icon
Restaurant Brands International
QSR
+$127M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$285M
2
TWX
Time Warner Inc
TWX
+$143M
3
CVS icon
CVS Health
CVS
+$142M
4
TMUS icon
T-Mobile US
TMUS
+$123M
5
META icon
Meta Platforms (Facebook)
META
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Consumer Discretionary 15.25%
3 Technology 14.69%
4 Industrials 11.95%
5 Financials 11.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADXS
1376
DELISTED
Advaxis Inc
ADXS
$75K ﹤0.01%
+2,968
New +$111K
FCEL icon
1377
FuelCell Energy
FCEL
$1.63B
$69K ﹤0.01%
+111
New +$70.4K
CRBP icon
1378
Corbus Pharmaceuticals
CRBP
$190M
$66K ﹤0.01%
+360
New +$80.9K
GLUU
1379
DELISTED
Glu Mobile Inc.
GLUU
$60K ﹤0.01%
15,883
-69,798
-81% -$262K
AVEO
1380
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$56K ﹤0.01%
1,921
– –
JILL icon
1381
J. Jill
JILL
$283M
$54K ﹤0.01%
2,919
-52,204
-95% -$1.67M
SDLP
1382
DELISTED
SEADRILL PARTNERS LLC
SDLP
$52K ﹤0.01%
1,897
-1,136
-37% -$38.6K
MEET
1383
DELISTED
The Meet Group, Inc. Common Stock
MEET
$52K ﹤0.01%
+24,983
New +$64.9K
TLGT
1384
DELISTED
Teligent, Inc
TLGT
$42K ﹤0.01%
+1,236
New +$39.3K
PDS
1385
Precision Drilling
PDS
$974M
$39K ﹤0.01%
710
-242,983
-100% -$16M
TRQ
1386
DELISTED
Turquoise Hill Resources Ltd
TRQ
$36K ﹤0.01%
1,170
-22,529
-95% -$711K
OPCH icon
1387
Option Care Health
OPCH
$3.56B
$35K ﹤0.01%
+3,548
New +$41K
PDLI
1388
DELISTED
PDL BioPharma, Inc.
PDLI
$35K ﹤0.01%
+11,819
New +$32.3K
EXK
1389
Endeavour Silver
EXK
$2.83B
$28K ﹤0.01%
+11,500
New +$27.4K
ONSIZ
1390
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$6K ﹤0.01%
125,100
– –
AAL icon
1391
American Airlines Group
AAL
$10.6B
– –
-73,095
Closed -$3.8M
ABCB icon
1392
Ameris Bancorp
ABCB
$5.89B
– –
-60,715
Closed -$2.93M
ACTG icon
1393
Acacia Research
ACTG
$470M
– –
-32,284
Closed -$131K
ADEA icon
1394
Adeia
ADEA
$3.11B
– –
-898,559
Closed -$5.8M
ADP icon
1395
Automatic Data Processing
ADP
$108B
– –
-73,316
Closed -$8.59M
ADTN icon
1396
Adtran
ADTN
$616M
– –
-322,324
Closed -$6.24M
AEE icon
1397
Ameren
AEE
$30.1B
– –
-19,535
Closed -$1.15M
AEM icon
1398
Agnico Eagle Mines
AEM
$90.5B
– –
-9,855
Closed -$457K
AGO icon
1399
Assured Guaranty
AGO
$3.34B
– –
-17,604
Closed -$596K
AIT icon
1400
Applied Industrial Technologies
AIT
$13.3B
– –
-61,703
Closed -$4.2M
54 55
56
57 58

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q1 2018 Portfolio in Review

As of Q1 2018, Marshall Wace North America held 1,901 positions worth $20B, up 10% from $18.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.7B of net new capital in Q1 2018, opening 565 new positions and adding to 401 existing holdings. Its largest new stake was Citigroup: 2,429,984 shares worth $164M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $285M trimmed.

  • Marshall Wace North America's largest Q1 2018 buy was Citigroup: 2,429,984 shares worth $164M.
  • Marshall Wace North America added most to Microsoft in Q1 2018, an estimated $328M increase.
  • Marshall Wace North America's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $285M.
  • Marshall Wace North America fully exited Manulife Financial in Q1 2018, selling an estimated $83.9M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $20B portfolio in Q1 2018.
  • Marshall Wace North America opened 565 new positions and closed 510 in Q1 2018.
  • Marshall Wace North America's portfolio value rose 10% quarter-over-quarter to $20B.

Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.